rediff.com
India As It Happens
India As It Happens
Rediff Labs will showcase innovative products that rediff is working on behind the scenes.
rediff News App
Hi Guest
About 1225 results for "fda "
 |
FDA says Merck drug helps treat insomnia but may cause daytime...WASHINGTON Federal health regulators say an experimental insomnia drug from Merck can help patients fall asleep, but it also carries worrisome side effects, including daytime drowsiness and suicidal thinking. The Food and Drug Administration ... Washington Post, 2 hours ago |
See all (4445) images for "fda " | ||||
See all (4445) images for "fda "
FDA Approves Morning-After Pill for Teenage GirlsImage: Plan B One-Step (Photo courtesy of Teva Pharmaceuticals). The US Food and Drug Administration (FDA; Silver spring, MD, USA) has approved the sale of the emergency oral contraceptive Plan B One-Step without a prescription to girls aged 15 ... Hospi Medica, 2 hours ago
FDA approves Plan B for girls as young as 15
Reuters, 2 weeks ago
|
Rediff.com
|
Peregrine Pharma agrees with FDA on lung cancer trial design2:36pm BST May 20 (Reuters) - Peregrine Pharmaceuticals said it reached an agreement with the U.S. Food and Drug Administration on the design of a late-stage trial for its experimental lung cancer drug. The late-stage trial will compare a ... Reuters UK, 4 hours ago
Peregrine Pharma Enters Into Deal With FDA On Bavituximab Phase III Trial Design
RTTNews.com, 4 hours ago
Peregrine Pharmaceuticals Reaches Agreement With FDA on a Phase III Trial Design for Bavituximab in Second-Line Non-Small Cell Lung Cancer
BusinessWeek, 4 hours ago
Peregrine Pharmaceuticals (PPHM) and the FDA agree on a Phase III trial design for Bavituximab. "We will now focus on starting the Phase III trial while continuing ongoing partnering discussions," says CEO Steven King. Shares halted. (PR)
Seeking Alpha, 4 hours ago
|
ITechPost
|
Cubist receives fast track status from FDA for anti-infective drugCubist Pharmaceuticals, Inc., a biopharmaceutical company, has received fast track status from the FDA for the company's late-stage antibiotic candidate ceftolozane/tazobactam in the previously granted Qualified Infectious Disease Product, or QIDP, ... Individual.com, 3 hours ago
FDA Grants Premarket Approval PMA For The SEDASYS System For Healthy Patients Undergoing Sedation During Routine Colonoscopy And EGD Procedures
Pharmacy Choice, 7 hours ago
US FDA approves Janssen Biotech 's Simponi for treatment of ulcerative colitis
PharmaBiz, 3 days ago
FDA approves J&J's Simponi to treat ulcerative colitis
Reuters, 4 days ago
|
Roll Call Online
|
Jiangsu Hengrui Gets FDA Drug CertificationJiangsu Hengrui Medicine Co., Ltd. (SHSE: 600276) revealed that a notice has been received from the Food and Drug Administration (FDA) saying that letrozole tablet produced by the company has gotten certification from the government agency and ... Individual.com, 5 hours ago
Sequester Withholding of FDA User Fees Irks Industry
Roll Call Online, 2 days ago
FDA Urges Hospitals to Check Mattresses
Hospi Medica, 4 days ago
FDA allows continued sale of generic Opana painkiller
Inside Counsel, 4 days ago
More from: India Infoline, DNA...and 8 other sources
|
Thoratec Corporation gets US FDA nod to market HeartMate II Pocket ControllerThoratec Corporation, a world leader in device-based mechanical circulatory support therapies to save, support and restore failing hearts, has received the US Food and Drug Administration (FDA) approval to market the HeartMate II Pocket Controller, ... PharmaBiz, 12 hours ago
Thoratec Gets FDA Nod To Sell HeartMate II Pocket Controller
RTTNews.com, 3 days ago
FDA Approves Thoratec's HeartMate II Pocket Controller
QMED, 2 days ago
Thoratec wins FDA nod for HeartMate controller
FiercePharma, 2 days ago
|
RTTNews.com
|
FDA approves Xofigo drug for late-stage prostate cancerAccording to the National Cancer Institute, an estimated 238,590 men will be diagnosed with prostate cancer and 29,720 will die from the disease in 2013. Credits: Yahoo Images Holistic Health newsletter E-mail * do not change Contact Email Contact ... Examiner.com, 2 hours ago
FDA Approves Oramed Pharmaceuticals, Inc. (NASDAQ:ORMP)?s Flagship Drug Plans ? ORMP, GILD, MNKD, CLSN, ONTY
Galaxy Stocks, 3 hours ago
FDA approves GSK's Breo Ellipta to treat COPD
Center Watch, 2 days ago
Oramed Pharma (ORMP) OK'd by FDA for ORMD-0801 IND
Street Insider, 3 days ago
|
Bio Spectrum Asia
|
Israel firm gets FDA nod for insulin trials in the USBio Spectrum Asia, 8 hours ago |
US FDA issues draft guideline on expanded access to IND for treatment; expects industry views before July 1The US Food and Drug Administration (FDA) has now issued a draft guideline on expanded access to investigational new drugs (IND) for treatment use in a 21 questions and answers format. The regulatory authority is now seeking the responses on this by ... PharmaBiz, 15 hours ago
FDA's tobacco head plans to move quickly on industry issues [Richmond Times-Dispatch, Va.]
BusinessWeek, 3 days ago
|
QRx to face FDA panel in JulyThe advisory panel to the US Food & Drug Administration (FDA) will meet in mid-July 2013 to review QRxPharma's resubmitted application for its painkiller MoxDuo. In July 2012, the FDA refused to accept the drug on the grounds that it combined two ... Individual.com, 23 hours ago
QRxPharma to face FDA panel in July
Australian Financial Review, 3 days ago
FDA reviewing robot complaints
New York Business Journal, 2 days ago
FDA Panel to Review New Avandia Results
Med India, 1 month ago
|
Prev
| Next
Personalize your Realtimeclose [x]
Add content to your personalized tab - My News
Add upto 6 topics of your interest:
for eg.2g Scam , World
1.
2.
3.
4.
5.
6.
Personalize the tabs display. ( You can add or remove the tabs )
►AlertsGet updates on latest news & your favourite topics right in your inbox.Set an Alert|Manage your Alerts
rediff News App
Alerts
Get updated on latest news & your favorite topics right in your inbox!
Widget
Get Realtime News on your webpage & get your members hooked!
Happening by Location
Click on any location on map to view latest news by location
